China Shineway Pharmaceutical Group Limited (FRA:C1S)
0.9200
0.00 (0.00%)
Last updated: Jul 30, 2025
Intra-Cellular Therapies Market Cap
FRA:C1S has a market cap or net worth of €678.43 million as of August 1, 2025. Its market cap has decreased by -4.60% in one year.
Market Cap
678.43M
Enterprise Value
-43.44M
Revenue
499.95M
Ranking
n/a
PE Ratio
6.10
Stock Price
$0.92
Market Cap Chart
Since December 2, 2004, FRA:C1S's market cap has increased from 374.00M to 678.43M, an increase of 81.40%. That is a compound annual growth rate of 2.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 678.43M | -25.16% |
Dec 31, 2024 | 906.47M | 42.53% |
Dec 29, 2023 | 636.01M | -7.56% |
Dec 30, 2022 | 688.04M | 17.23% |
Dec 31, 2021 | 586.90M | 38.92% |
Dec 31, 2020 | 422.49M | -35.30% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 284.92B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 151.49B |
Allianz SE | 127.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 78.24B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 73.00B |
Deutsche Bank Aktiengesellschaft | 55.70B |